v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2025
Apr. 30, 2024
Operating activities    
Net income (loss) $ (110,993) $ 46,264
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 56,423 42,689
Amortization of intangible assets 7,634 5,995
Amortization of deferred contract acquisition costs 102,903 74,128
Non-cash operating lease cost 4,186 3,372
Stock-based compensation expense 253,604 183,125
Deferred income taxes (1,681) (255)
Realized gains on strategic investments 0 (6,881)
Non-cash interest expense 1,088 874
Change in fair value of strategic investments 1,579 0
Accretion of short-term investments purchased at a discount 0 2,285
Changes in operating assets and liabilities, net of impact of acquisitions    
Accounts receivable, net 319,871 150,249
Deferred contract acquisition costs (102,803) (66,480)
Prepaid expenses and other assets (20,995) (28,602)
Accounts payable (83,228) 276
Accrued expenses and other liabilities (43,763) (16,629)
Accrued payroll and benefits (37,848) (17,692)
Operating lease liabilities (4,586) (4,531)
Deferred revenue 42,716 15,041
Net cash provided by operating activities 384,107 383,228
Investing activities    
Purchases of property and equipment (85,751) (49,683)
Capitalized internal-use software and website development costs (17,437) (10,479)
Purchases of strategic investments (374) (1,658)
Proceeds from sales of strategic investments 3,146 10,407
Business acquisitions, net of cash acquired 0 (96,376)
Proceeds from maturities and sales of short-term investments 0 97,300
Purchases of deferred compensation investments (1,459) (609)
Proceeds from sales of deferred compensation investments 45 0
Net cash used in investing activities (101,830) (51,098)
Financing activities    
Proceeds from the issuance of common stock upon exercise stock options 634 823
Distributions to non-controlling interest holders 0 (3,841)
Capital contributions from non-controlling interest holders 1,500 500
Net cash provided by (used in) financing activities 2,134 (2,518)
Effect of foreign exchange rates on cash, cash equivalents and restricted cash 6,546 (1,917)
Net increase in cash, cash equivalents and restricted cash 290,957 327,695
Cash, cash equivalents and restricted cash at beginning of period 4,324,666 3,377,597
Cash, cash equivalents and restricted cash at end of period 4,615,623 3,705,292
Cash and cash equivalents 4,614,153 3,702,437
Restricted cash included in prepaid expenses and other assets 1,470 2,855
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows 4,615,623 3,705,292
Supplemental disclosure of cash flow information:    
Interest paid 11,250 11,250
Income taxes paid, net of refunds received 17,026 7,594
Supplemental disclosure of non-cash investing and financing activities:    
Net decrease in property and equipment included in accounts payable and accrued expenses (32,212) (17,655)
Equity consideration for acquisitions 0 468
Operating lease liabilities arising from obtaining operating right-of-use assets 0 1,759
Proceeds from sales of strategic investments not yet received 1,846 4,734
Stock-based compensation included in capitalized software development costs and fixed assets 13,291 7,966
Noncash consideration for the purchase of strategic investments 0 3,319
Noncash consideration received from sales of strategic investments $ 0 $ 3,319